Inscripciones / Registration
La inscripción es gratuita y estará abierta hasta el día 2 de junio a las 12:00 (CEST) a través del siguiente formulario:
El enlace se enviará al correo electrónico facilitado antes del inicio del webinar. En caso de no recibir el enlace, por favor, revise su carpeta de correo no deseado o contacte con firstname.lastname@example.org.
Registration is free and will be available until 2 June at 12:00 (CEST) by filling in the form:
The link will be sent to the email address provided before the webinar starts. If you do not receive the link, please check your spam folder or contact email@example.com.
George is a steering member of the Health and Environmental Sciences Institute (HESI) Genetic Toxicology Technical Committee (GTTC) and co-chair of the quantitative and mode of action subgroups. The HESI provides an international forum to advance the understanding of scientific issues related to human health, toxicology, risk assessment, and the environment.
George has been invited to give oral presentations and chair sessions at most of the major international Toxicology conferences in recent years.
George has been lead academic on numerous international collaborations. These include US-FDA-NCTR, Health Canada, RIVM-Netherlands, AstraZeneca, Drugs for Neglected Disease Initiative (DNDi), Food Standards Agency, GlaxoSmithKline, Gentronix, Hoffman-La-Roche, Litron, and more. He also continues to work with the DNA damage group (in vitro Toxicology group) in the Institute of Life Science, as well as teaching on the Genetics Degree programme, and having a role as Director of Employability and Entrepreneurship for the Medical School.
George was awarded the prestigious UKEMS Young Scientist Award in 2012, in 2013 he became a Fellow of the Higher Education Academy, and in 2014 he became a British & European Registered Toxicologist and also won the very prestigious EEM(G)S Young Scientist Award.
In June 2017 George was voted in as President-Elect for the EEMGS society, and became President in 2019.
George has recently become a consultant, with clients including the pharmaceutical, food additive and chemical industries. A major aspect of many of these projects has been the derivation of point of departure metrics for use in human health risk assessments. Please contact him for further information on his services, which he runs through Swansea Innovations.